Celon Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Celon Pharma has a total shareholder equity of PLN516.2M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN619.2M and PLN102.9M respectively. Celon Pharma's EBIT is PLN22.4M making its interest coverage ratio 3.8. It has cash and short-term investments of PLN24.9M.
Key information
0%
Debt to equity ratio
zł0
Debt
| Interest coverage ratio | 3.8x |
| Cash | zł24.92m |
| Equity | zł516.25m |
| Total liabilities | zł102.91m |
| Total assets | zł619.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8RP's short term assets (PLN193.3M) exceed its short term liabilities (PLN72.3M).
Long Term Liabilities: 8RP's short term assets (PLN193.3M) exceed its long term liabilities (PLN30.6M).
Debt to Equity History and Analysis
Debt Level: 8RP is debt free.
Reducing Debt: 8RP had no debt 5 years ago.
Debt Coverage: 8RP has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8RP has no debt, therefore coverage of interest payments is not a concern.